Comparative in vitro activity of bacteriophage endolysin HY-133 against Staphylococcus aureus attached to vascular graft surface

Med Microbiol Immunol. 2020 Feb;209(1):51-57. doi: 10.1007/s00430-019-00638-1. Epub 2019 Oct 17.

Abstract

Novel strategies are needed for combating Staphylococcus aureus biofilm in vascular graft infections. We investigated the in vitro activity of bacteriophage endolysin HY-133, daptomycin and rifampin against S. aureus attached to vascular graft surface. Daptomycin showed rapid bactericidal effect on surface-associated S. aureus, while the activity of HY-133 on graft surface-adherent cells was moderate and rifampin did not achieve bactericidal effect. Even in the highest concentrations, all antimicrobials used failed in a complete eradication of the surface-adherent bacteria.

Keywords: Antibiotics; Bacteriophage endolysin; Biofilm; HY-133; Resistance; Staphylococcus aureus.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Bacteriophages / enzymology*
  • Biofilms
  • Endopeptidases / pharmacology*
  • Humans
  • Microbial Sensitivity Tests
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology*
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / physiology*
  • Vascular Grafting
  • Vasculitis / microbiology*

Substances

  • Anti-Bacterial Agents
  • Endopeptidases
  • endolysin